BANK OF AMERICA CORP /DE/
BankPosition in FULC — Fulcrum Therapeutics, Inc.
CIK 70858
CHARLOTTE, NC
Position in FULC
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$3,817,485
+$2,846,778 QoQ
Shares Held
1,043,029
+724.1% QoQ
Ownership
1.37%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#24
of 154 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in FULC Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026BANK OF AMERICA CORP /DE/ holds $10,050,306,032 across 338 Biotechnology names. FULC ranks #154 (0.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
3,039,178 | $1,509,650,884 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
1,291,053 | $805,023,185 | |
| 3 | CYTK |
Cytokinetics Inc
|
4,635,709 | $394,916,048 | |
| 4 | ARGX |
Argenx SE
|
400,234 | $371,325,094 | |
| 5 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
994,476 | $299,367,107 | |
| 6 | JAZZ |
Jazz Pharmaceuticals plc
|
1,136,091 | $273,763,844 | |
| 7 | TVTX |
Travere Therapeutics, Inc.
|
4,568,341 | $259,527,450 | |
| 8 | RPRX |
Royalty Pharma plc
|
4,149,422 | $232,658,090 |
All Filings in FULC
Export CSV
27 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $3,817,485 | 1,043,029 | Shares | Defined | 2026-08-14 | |
| 2026-06-30 | $16,353,330 | 4,468,123 | Shares | Sole | 2026-08-03 | |
| 2026-03-31 | $970,707 | 126,559 | Shares | Defined | 2026-05-18 | |
| 2025-12-31 | $2,614,610 | 231,177 | Shares | Defined | 2026-02-17 | |
| 2025-09-30 | $1,354,340 | 147,211 | Shares | Defined | 2026-02-03 | |
| 2025-06-30 | $316,403 | 45,989 | Shares | Defined | 2025-08-14 | |
| 2025-03-31 | $161,668 | 56,135 | Shares | Defined | 2025-05-15 | |
| 2024-12-31 | $431,770 | 91,866 | Shares | Defined | 2025-02-14 | |
| 2024-09-30 | $356,696 | 99,915 | Shares | Defined | 2024-11-14 | |
| 2024-06-30 | $433,292 | 69,886 | Shares | Defined | 2024-08-14 | |
| 2024-03-31 | $582,004 | 61,653 | Shares | Defined | 2024-05-15 | |
| 2023-12-31 | $1,265,435 | 187,472 | Shares | Defined | 2024-02-14 | |
| 2023-09-30 | $617,354 | 139,044 | Shares | Defined | 2023-11-14 | |
| 2023-06-30 | $436,384 | 132,238 | Shares | Defined | 2023-08-14 | |
| 2023-03-31 | $120,752 | 42,370 | Shares | Defined | 2023-05-12 | |
| 2022-12-31 | $419,567 | 57,633 | Shares | Defined | 2023-02-10 | |
| 2022-09-30 | $241,226 | 29,818 | Shares | Defined | 2022-11-14 | |
| 2022-06-30 | $507,967 | 103,667 | Shares | Defined | 2022-08-12 | |
| 2022-03-31 | $350,752 | 14,831 | Shares | Defined | 2022-05-16 | |
| 2021-12-31 | $494,682 | 27,964 | Shares | Defined | 2022-02-08 | |
| 2021-09-30 | $210,671 | 7,468 | Shares | Defined | 2021-11-15 | |
| 2021-06-30 | $107,702 | 10,277 | Shares | Defined | 2021-09-13 | |
| 2021-03-31 | $58,958 | 5,005 | Shares | Defined | 2021-05-14 | |
| 2020-12-31 | $198,741 | 16,972 | Shares | Defined | 2021-02-10 | |
| 2020-09-30 | $29,079 | 3,667 | Shares | Defined | 2020-11-13 | |
| 2020-06-30 | $298,711 | 16,332 | Shares | Defined | 2020-08-14 | |
| 2020-03-31 | $185,236 | 15,514 | Shares | Defined | 2020-05-15 | |
| No filing history on record for this holder in this stock. | ||||||